The Nasdaq and S&P 500 joined the Dow into negative territory late Wednesday, as crude oil spiked higher.
At 2:43 EDT, the NYSE composite was up 0.2%, helped by gains in oil-related issues.
In late trading, crude surged $3.84, or 4%, to $104.82 a barrel.
The Dow slipped 0.4%. Meanwhile, the Nasdaq and S&P 500 fell 0.2% each.
Volume was again mixed, with the NYSE’s lower and Nasdaq’s higher.
On the downside, Intermec () dropped 1.88, or 8%, to 21.02 in heavy trading. Stanford Research started coverage of the data collections systems maker with a sell rating. The stock also sliced its 50-day moving average.
Salesforce.com () gained 1.83 to 63.05. Earlier, the provider of customer relationship management products and service cleared a 63.57 buy point of a cup-with-handle pattern. In the past two quarters, profit surged 400% and 500%, respectively. Another triple-digit gain is expected in the current period. But the stock has a return on equity of 5%, or well below the average 17% seen in past winners.
Southwestern Energy () climbed 2.33 to a new high of 36.10. The Texas-based oil and natural gas producer emerged from its third pullback to its 10-week line since its Oct. 26 breakout.
Baidu.com () tacked on 10 points to 283.25 and regained its 50-day moving average. But it pulled back from session highs of 292.
1:15 p.m. Update: Indexes Mixed In Midday Trading
By VINCENT MAO
The major stock indexes traded in split fashion midday Wednesday.
At 12:40 p.m. EDT, the Nasdaq and NYSE composite were up 0.4% each. The S&P 500 rose 0.2%. The Dow slipped 0.1%.
Volume was tracking lower on the NYSE and just barely higher on the Nasdaq.
Solera Holdings () jumped 1.30, or 5%, to a new high of 26.63. The software maker cleared a 26.60 buy point of a cup-shaped base. It has already traded 150% of its average daily volume.
Forest Oil () gapped up and gained 1.64 to a multiyear of 54.13. The oil and gas producer followed through after clearing a 52.32 buy point from a 13-week consolidation Tuesday.
May crude slipped 28 cents to $100.70 a barrel, following a mixed inventories report.
II-VI () added 0.67 to trade at a new high of 38.97. The company makes infrared products for the aerospace, medical, military and security markets. It reports earnings April 22. Profit is slated to rise 21% to 40 cents a share.
On the downside, FTI Consulting () slumped 4.79, or 8%, to 64.18 in heavy trading. That knocked the stock’s Accumulation/Distribution Rating down to a C from an A just four sessions ago. The firm’s profit growth has slowed for the past two quarters. Analysts see the trend continuing in the current period.
11:15 a.m. Update: Stocks Move Steadily Higher In Soft Volume
By ALAN R. ELLIOTT
Indexes whistled past comments by Fed Chief Ben Bernanke about a shrinking economy in the first half of the year. Financials, residential builders and technology stocks posted solid advances.
The NYSE composite logged a 0.4% gain, and the Nasdaq added 0.6%, at 10:50 a.m. EDT. Citigroup (), Goldman Sachs (), Wachovia () and Apple () posted modest gains in strong volume, lifting the S&P 500 0.3%. Merck (), Caterpillar (), Coca-Cola () and United Technologies () pulled down in strong volume, holding the Dow to a 0.2% advance.
Asian markets gained ground, borrowing confidence from Monday’s leap by U.S. stocks. Hong Kong’s Hang Seng index jumped 3.2% to a one-month high. Financials led there, too. Fears of a slowing economy and a glut of liquidity in mainland markets reeled the Shanghai composite back to a 0.6% gain after a 4.1% intraday surge. Tokyo’s Nikkei 225 sped to a 4.2% gain, its best showing since Feb. 14, as the dollar continued to firm vs. the yen.
London’s FTSE 100 edged up 0.6%. The CAC 40 in Paris clocked a 0.9% gain.
Lindsay () jumped 4.83 to 110.24 in powerful volume. The maker of irrigation equipment broke above an 81.44 pullback buy point after announcing a Q2 earnings leap March 19. It is now 35% above that buy point, plowing into new highs in strong volume.
China-based search engine Baidu.com () swelled 16.25 to 289.50. Shares are turning up after a three-month slide, and back above their 10-week moving average for the first time since January.
Inpatient services provider Psychiatric Solutions () slipped 1.78 to 32. Shares rebounded to the midpoint of the morning’s trading range after a huge-volume fall. That kept them just above their 10-week moving average, but the stock remains well below its 40-week line.
10:15 a.m. Update: Stocks Retreat In Early Trading
By VINCENT MAO
Stocks pulled back early Wednesday following the prior session’s monster gains.
At 9:56 a.m. EDT, the Dow and NYSE composite gave up 0.4% and 0.2%, respectively. The Nasdaq and S&P 500 each fell 0.3%.
Volume was tracking lower on both exchanges.
In prepared testimony to Congress’ Joint Economic Committee, Fed Chairman Ben Bernanke said “it now appears likely that gross domestic product will not grow much, if at all, over the first half of 2008 and could even contract slightly.” This pointed to a recession, but Bernanke didn’t use the “R” word. He sounded more optimistic about the second half of 2008.
Monsanto () gapped down and lost 2.66 to 110.29 after its outlook disappointed. Before the open, the agricultural operations firm reported fiscal Q2 earnings, excluding items, of $1.79 a share. That was up 81% from a year ago and 4 cents above views. The company cited strong demand in its seed, traits and herbicides units. But Monsanto guided full-year income in a range of $3.15 to $3.25 a share vs. views of $3.20.
State Street () fell 2.01 to 82.83 on a downgrade. Keefe, Bruyette & Woods cut the investment management and services firm to market perform from outperform, on belief State Street will face a difficult environment in the second-half of the year. State Street has been building a double-bottom base with a buy point at 85.86. But it has added a handle, giving a slightly lower entry point at 85.31.
On the upside, Research In Motion () added 0.67 to 118.15 ahead of its earnings report, slated for after the close. The BlackBerry smart phone maker is expected to earn 70 cents a share on sales of $1.86 billion.
VimpelCom () jumped 1.83, or 6%, to 32.89 in fast trade. The Russian telecom firm is trying to bounce back after a 37% decline from its December high. It regained its 50-day moving average Tuesday in heavy trading.
9:15 a.m. Update: ADP Report Lifts Stock Futures
By VINCENT MAO
Stock futures pointed to a slightly higher Wednesday, following a better-than-expected ADP employment report.
Nasdaq futures rose 3 points vs. fair value, S&P 500 futures gained 2 points and Dow futures tacked on 3 points.
Fed Chief Ben Bernanke will be speaking at 9:30 a.m. EDT on the status of the economy.
In economic news, the ADP employment survey said the economy gained 8,000 private sector jobs in March vs. expectations for a loss of 45,000. February figures were revised to minus 18,000 from minus 23,000.
The Labor Department’s report will be out Friday. Economists expect a loss of 50,000 jobs, both public and private.
Data on February orders will be out at 10 a.m. EDT. A decline of 0.8% is expected, but this is a minor report.
At 10:30 a.m. EDT, the weekly energy inventory report will be out. May crude oil rose 17 cents to $101.15 a barrel.
AstraZeneca () slipped 1% in the pre-open after a mix of analysts changes. HSBC cut the drug maker to neutral from overweight on valuation, but Citigroup lifted shares to buy from hold.
Best Buy () jumped 7% in pre-market trading after it topped profit estimates. The electronics retailer reported fiscal Q4 earnings of $1.71 a share, up 10% from a year ago and 6 cents ahead of views. Sales edged 4% to $13.42 billion. Best Buy guided full-year fiscal 2009 profit in a range of $3.25 to $3.40 a share vs. analysts’ estimates of $3.31 a share. Rival Circuit City () climbed 4% in the pre-market.
Caterpillar () said late Tuesday in a regulatory filing that it’s raising prices by up to 5%. The construction and mining equipment maker cited “general economic conditions and industry factors.” The Dow component edged higher in the pre-market.
Immucor () rallied 7% in the pre-open on strong earnings. Late Tuesday, the maker of blood-testing equipment reported fiscal Q3 profit of 27 cents a share, up 29% from the prior year and a nickel above views. Sales rose 17% to $67 million.